Methylphenidate effects on neural activity during response inhibition in healthy humans

Cerebral Cortex

Volumn 23, Issue 5, 2013, Pages 1179-1189

  Costa, Anna ^a   Riedel, Michael ^a,c   Pogarell, Oliver ^a   Menzel Zelnitschek, Frank ^a   Schwarz, Markus ^a   Reiser, Maximilian ^b   Möller, Hans Jürgen ^a   Rubia, Katya ^d   Meindl, Thomas ^b   Ettinger, Ulrich ^a,e  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Clinic for Psychiatry   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

dopamine; fMRI; human; methylphenidate; response inhibition

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG INHIBITION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NERVE CELL; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DECISION MAKING; DOUBLE-BLIND METHOD; HUMANS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; MIDDLE AGED; NEURAL INHIBITION; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84876176101     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs107     Document Type: Article

References (96)

1. Alderson RM, Rapport MD, Kofler MJ. 2007. Attention-deficit/hyperac- tivity disorder and behavioral inhibition: a meta-analytic review of the stop-signal paradigm. J Abnorm Child Psychol. 35:745-758.
2. Anderson IM, Clark L, Elliott R, Kulkarni B, Williams SR, Deakin JF. 2002. 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport. 13:1547-1551.
3. Arnsten AF. 2006a. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatr. 67(Suppl 8):7-12.
4. Arnsten AF. 2006b. Stimulants: therapeutic actions in ADHD. Neurop-sychopharmacology. 31:2376-2383.
5. Aron AR. 2007. The neural basis of inhibition in cognitive control. Neuroscientist. 13:214-228.
6. Aron AR, Dowson JH, Sahakian BJ, Robbins TW. 2003a. Methylpheni-date improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatr. 54:1465-1468.
7. Aron AR, Durston S, Eagle DM, Logan GD, Stinear CM, Stuphorn V. 2007. Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci. 27: 11860-11864.
8. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. 2003b. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci. 6:115-116.
9. Aron AR, Poldrack RA. 2005. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hy-peractivity disorder. Biol Psychiatr. 57:1285-1292.
10. Bauer H, Pripfl J, Lamm C, Prainsack C, Taylor N. 2003. Functional neuroanatomy of learned helplessness. Neuroimage. 20: 927-939.
11. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R. 2003. Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol. 31:315-327.
12. Bedard AC, Schulz KP, Cook EH, Jr, Fan J, Clerkin SM, Ivanov I, Hal-perin JM, Newcorn JH. 2010. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuro-image. 53:935-942.
13. Bellgrove MA, Hester R, Garavan H. 2004. The functional neuroanato-mical correlates of response variability: evidence from a response inhibition task. Neuropsychologia. 42:1910-1916.
14. Berto D, Peroni M, Milleri S, Spagnolo AG. 2000. Evaluation of the readability of information sheets for healthy volunteers in phase-I trials. Eur J Clin Pharmacol. 56:371-374.
15. Braver TS, Cohen JD. 2000. On the control of control: the role of dopamine in regulating prefrontal function and working memory. Control Cogn Process Attent Perform XVIII. 18:713-737.
16. Brett M, Anton JL, Valabregue R, Poline JB. 2002. Region of interest analysis using an SPM toolbox [abstract]. Paper Presented at the 8th International Conference on Functional Mapping of the Human Brain, Sendai, Japan.
17. Bromberg-Martin ES, Matsumoto M, Hikosaka O. 2010. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 68:815-834.
18. Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E et al. 2008. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatr. 65:102-114.
19. Chamberlain SR, Hampshire A, Muller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE et al. 2009. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatr. 65:550-555.
20. Chambers CD, Garavan H, Bellgrove MA. 2009. Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev. 33:631-646.
21. Chikazoe J, Jimura K, Asari T, Yamashita K, Morimoto H, Hirose S, Miyashita Y, Konishi S. 2009. Functional dissociation in right inferior frontal cortex during performance of go/no-go task. Cereb Cortex. 19:146-152.
22. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD et al. 2009. Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci. 29:4690-4696.
23. Cubillo A, Smith A, Barrat N, Giampietro V, Rubia K. 2011. Task-dependent drug-specific upregulation effects of methylphenidate and atomoxetine on brain function in medication-naïve children with ADHD. Eur J Psychopharmacol. 19:S303.
24. DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, Aitken MR, Sahakian BJ. 2009. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharma-cology (Berl). 202:531-539.
25. Dodds CM, Muller U, Clark L, van Loon A, Cools R, Robbins TW. 2008. Methylphenidate has differential effects on blood oxygen-ation level-dependent signal related to cognitive subprocesses of reversal learning. J Neurosci. 28:5976-5982.
26. Durston S, Thomas KM, Yang Y, Ulug AM, Zimmerman RD, Casey B. 2002. A neural basis for the development of inhibitory control. Dev Sci. 5:F9-F16.
27. Durston S, Tottenham NT, Thomas KM, Davidson MC, Eigsti IM, Yang Y, Ulug AM, Casey BJ. 2003. Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatr. 53:871-878.
28. Eagle DM, Bari A, Robbins TW. 2008. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl). 199:439-456.
29. Epstein JN, Casey BJ, Tonev ST, Davidson MC, Reiss AL, Garrett A, Hinshaw SP, Greenhill LL, Glover G, Shafritz KM et al. 2007. ADHD-and medication-related brain activation effects in concor-dantly affected parent-child dyads with ADHD. J Child Psychol Psychiatr. 48:899-913.
30. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K et al. 2006. Assessing medication effects in the MTA study using neuropsycho-logical outcomes. J Child Psychol Psychiatr. 47:446-456.
31. Ettinger U, Corr PJ. 2001. The Frequency Accrual Speed Test (FAST): psychometric intelligence and personality correlates. Eur J Person. 15:143-152.
32. Evers EA, van der Veen FM, van Deursen JA, Schmitt JA, Deutz NE, Jolles J. 2006. The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers. Psychopharmacology (Berl). 187:200-208.
33. Finke K, Dodds CM, Bublak P, Regenthal R, Baumann F, Manly T, Muller U. 2010. Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. Psychopharmacology (Berl). 210:317-329.
34. Flehmig HC, Steinborn M, Langner R, Scholz A, Westhoff K. 2007. Assessing intraindividual variability in sustained attention: reliability, relation to speed and accuracy, and practice effects. Psychol Sci. 49:132.
35. Garavan H, Ross TJ, Murphy K, Roche RA, Stein EA. 2002. Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage. 17:1820-1829.
36. Gray JR, Kagan J. 2000. The challenge of predicting which children with attention deficit-hyperactivity disorder will respond positively to methylphenidate. J Appl Dev Psychol. 21:471-489.
37. Greenhill LL, Halperin JM, Abikoff H. 1999. Stimulant medications. J Am Acad Child Adolesc Psychiatr. 38:503-512.
38. Groen Y, Mulder LJ, Wijers AA, Minderaa RB, Althaus M. 2009. Methylphenidate improves diminished error and feedback sensitivity in ADHD: an evoked heart rate analysis. Biol Psychol. 82:45-53.
39. Hazy TE, Frank MJ, O'Reilly RC. 2007. Towards an executive without a homunculus: computational models of the prefrontal cortex/basal ganglia system. Phil Trans R Soc Lond B Biol Sci. 362:1601-1613.
40. Hershey T, Black KJ, Hartlein J, Braver TS, Barch DM, Carl JL, Perl-mutter JS. 2004. Dopaminergic modulation of response inhibition: an fMRI study. Brain Res Cogn Brain Res. 20:438-448.
41. Klein C, Wendling K, Huettner P, Ruder H, Peper M. 2006. Intra-subject variability in attention-deficit hyperactivity disorder. Biol Psychiatr. 60:1088-1097.
42. Kobel M, Bechtel N, Weber P, Specht K, Klarhofer M, Scheffler K, Opwis K, Penner IK. 2009. Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactiv-ity disorder. Eur J Paediatr Neurol. 13:516-523.
43. Koren G. 2003. Healthy children as subjects in pharmaceutical research. Theor Med Bioeth. 24:149-159.
44. Krusch DA, Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD, Strauss J. 1996. Methylphenidate slows reactions of children with attention deficit disorder during and after an error. J Abnorm Child Psychol. 24:633-650.
45. Lansbergen MM, Kenemans JL, van Engeland H. 2007. Stroop interference and attention-deficit/hyperactivity disorder: a review and meta-analysis. Neuropsychology. 21:251-262.
46. Lee SH, Song DH, Kim BN, Joung YS, Ha EH, Cheon KA, Shin YJ, Yoo HJ, Shin DW. 2009. Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder. Yonsei Med J. 50:650-655.
47. Lee YS, Han DH, Lee JH, Choi TY. 2010. The effects of methylpheni-date on neural substrates associated with interference suppression in children with ADHD: a preliminary study using event related fMRI. Psychiatr Investig. 7:49-54.
48. Leth-Steensen C, King Elbaz Z, Douglas VI. 2000. Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psychol. 104:167-190.
49. Liddle PF, Kiehl KA, Smith AM. 2001. Event-related fMRI study of response inhibition. Hum Brain Mapp. 12:100-109.
50. Logan GD, Schachar RJ, Tannock R. 1997. Impulsivity and inhibitory control. Psychol Sci. 8:60.
51. Maier SF, Seligman ME. 1976. Learned helplessness: theory and evidence. J Exp Psychol Gen. 105:3.
52. Marquand AF, De Simoni S, O'Daly OG, Williams SC, Mourao-Miranda J, Mehta MA. 2011. Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology. 36:1237-1247.
53. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. 2000. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci. 20:RC65.
54. Menon V, Adleman NE, White CD, Glover GH, Reiss AL. 2001. Error-related brain activation during a Go/NoGo response inhibition task. Hum Brain Mapp. 12:131-143.
55. Mostofsky SH, Simmonds DJ. 2008. Response inhibition and response selection: two sides of the same coin. J Cogn Neurosci. 20:751-761.
56. Müller U. 2008. Pharmacological treatment. In: Cappa SF, Abutalebi J, Démonet J-F, Fletcher P, Garrard P. editors. Cognitive neurology: a clinical textbook. Oxford: Oxford University Press. p. 475-498.
57. Nandam LS, Hester R, Wagner J, Cummins TD, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA. 2011. Methyl-phenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatr. 69:902-904.
58. Nieoullon A. 2002. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 67:53-83.
59. Norris H. 1971. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology. 10:181-191.
60. Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cant-well DP, Conners CK, Elliott G, Greenhill LL, Hechtman L. 2003. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 71:540.
61. Peterson BS, Potenza MN, Wang Z, Zhu H, Martin A, Marsh R, Plessen KJ, Yu S. 2009. An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatr. 166:1286-1294.
62. Prehn-Kristensen A, Krauel K, Hinrichs H, Fischer J, Malecki U, Schuetze H, Wolff S, Jansen O, Duezel E, Baving L. 2011. Methyl-phenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder. Brain Res. 1388:56-68.
63. Rubia K, Halari R, Christakou A, Taylor E. 2009. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Phil Trans R Soc Lond B Biol Sci. 364:1919-1931.
64. Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. 2009. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology. 57:640-652.
65. Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M, Taylor E. 2011. Methylphenidate normalizes fronto-striatal under-activation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder. Neuropsychopharma-cology. 36:1575-1586.
66. Rubia K, Halari R, Mohammad AM, Taylor E, Brammer M. 2011. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Biol Psychiatr. 70:255-262.
67. Rubia K, Noorloos J, Smith A, Gunning B, Sergeant J. 2003. Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol. 31:301-313.
68. Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, Simmons A, Williams SC, Giampietro V, Andrew CM et al. 2001. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage. 13:250-261.
69. Rubia K, Smith AB, Brammer MJ, Taylor E. 2003. Right inferior prefrontal cortex mediates response inhibition while mesial pre-frontal cortex is responsible for error detection. Neuroimage. 20:351-358.
70. Rubia K, Smith AB, Taylor E. 2007. Performance of children with attention deficit hyperactivity disorder (ADHD) on a test battery of impulsiveness. Child Neuropsychol. 13:276-304.
71. Rubia K, Smith AB, Taylor E, Brammer M. 2007. Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Hum Brain Mapp. 28:1163-1177.
72. Rubia K, Smith AB, Woolley J, Nosarti C, Heyman I, Taylor E, Brammer M. 2006. Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Hum Brain Mapp. 27:973-993.
73. Schachar R, Logan GD, Robaey P, Chen S, Ickowicz A, Barr C. 2007. Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol. 35: 229-238.
74. Schlosser RG, Nenadic I, Wagner G, Zysset S, Koch K, Sauer H. 2009. Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylpheni-date challenge. Synapse. 63:429-442.
75. Schultz W. 2002. Getting formal with dopamine and reward. Neuron. 36:241-263.
76. Schultz W, Dayan P, Montague PR. 1997. A neural substrate of prediction and reward. Science. 275:1593-1599.
77. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S et al. 1987. Human brain dopamine receptors in children and aging adults. Synapse. 1:399-404.
78. Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA. 2004. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am J Psychiatr. 161: 1990-1997.
79. Sonuga-Barke EJS, Coghill D, Markowitz JS, Swanson JM, Vanden-berghe M, Hatch SJ. 2007. Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. J Am Acad Child Adolesc Psychiatr. 46:701-710.
80. Spencer SV, Hawk LW, Jr, Richards JB, Shiels K, Pelham WE, Jr, Wax-monsky JG. 2009. Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol. 37:805-816
81. SPSS. 2010. PASW STATISTICS 19.0 Command Syntax Reference. Chicago: SPSS Inc.
82. Talairach J, Tournoux P. 1988. Co-planar stereotaxic atlas of the human brain. New York (NY): Thieme.
83. Trommer BL, Hoeppner JA, Zecker SG. 1991. The go-no go test in attention deficit disorder is sensitive to methylphenidate. J Child Neurol. 6(Suppl):S128-S131.
84. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. 2003. Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology (Berl). 168:455-464.
85. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD. 1998. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA. 95:14494-14499.
86. van Mourik R, Oosterlaan J, Sergeant JA. 2005. The Stroop revisited: a meta-analysis of interference control in AD/HD. J Child Psychol Psychiatr. 46:150-165.
87. Verbruggen F, Logan GD. 2009. Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev. 33:647-661.
88. Verbruggen F, Logan GD. 2008. Response inhibition in the stop-signal paradigm. Trends Cogn Sci. 12:418-424.
89. Vink M, Kahn RS, Raemaekers M, van den Heuvel M, Boersma M, Ramsey NF. 2005. Function of striatum beyond inhibition and execution of motor responses. Hum Brain Mapp. 25: 336-344.
90. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitze-mann R, Pappas N. 1998. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphe-nidate. Am J Psychiatr. 155:1325-1331.
91. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D. 2001. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 21:RC121.
92. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P et al. 2004. Evidence that methyl-phenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatr. 161:1173-1180.
93. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y et al. 2009. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 302:1084-1091.
94. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM et al. 2007. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage. 34:1182-1190.
95. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attention-deficit/hyperactiv-ity disorder: a meta-analytic review. Biol Psychiatr. 57:1336-1346.
96. Zandbelt BB, Vink M. 2010. On the role of the striatum in response inhibition. PLoS One. 5:e13848.